The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010–2019 - Takeaways - MDSpire

The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010–2019

  • By

  • Jakhongir F. Alidjanov

  • Tommaso Cai

  • Riccardo Bartoletti

  • Gernot Bonkat

  • Franck Bruyère

  • Béla Köves

  • Ekaterina Kulchavenya

  • José Medina-Polo

  • Kurt Naber

  • Tamara Perepanova

  • Adrian Pilatz

  • Zafer Tandogdu

  • Truls E. Bjerklund Johansen

  • Florian M. Wagenlehner

  • February 22, 2021

  • 0 min

Share

  • 1

    Prostate biopsy is a common urological procedure, with over one million performed annually in the U.S., but infection rates have increased significantly.

  • 2

    Infective complications after prostate biopsy can include urinary tract infections and febrile complications, affecting 5.2% and 3.5% of patients, respectively.

  • 3

    Antimicrobial resistance among uropathogens has led to increased failure of antibiotic prophylaxis, highlighting the need for targeted antimicrobial stewardship.

  • 4

    The Global Prevalence Study of Infections in Urology analyzed data from 258 clinics across 55 countries, revealing trends in post-biopsy infections from 2010 to 2019.

  • 5

    Patient characteristics such as age and antibiotic history were evaluated to assess their impact on the risk of complications following prostate biopsy.

Original Source(s)

Related Content